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Background: It is not clear whether cystic fibrosis (CF) airway inflammation is a consequence of bacterial infection or is intrinsically
dysregulated. The aim of this study was to investigate IL-8 secretion and NF-nB activity in primary respiratory epithelial cells cultured from
nasal polyps obtained from CF and non-CF subjects.
Methods: NF-nB activity was studied by electrophoretic mobility-shift and quantitative colorimetric assays in nuclear extracts.
Immunoreactive IL-8 levels were assessed by ELISA in cell culture supernatants. Both parameters were studied at baseline and following
challenge with Pseudomonas aeruginosa or stimulation with pro-inflammatory cytokines.
Results: Under basal conditions, CF cells presented a significant higher activity of NF-nB than non-CF cells (P=0.0004). P. aeruginosa
challenge and IL-1h/H2O2 co-stimulation caused four and two fold induction of NF-nB activity in non-CF and CF cells, respectively. IL-
8 levels in unstimulated CF cells were significantly higher than in non-CF cells (P=0.0025). Upon incubation with P. aeruginosa and IL-1h/
H2O2, non-CF cells produced 6.3 times more IL-8 than unstimulated cells, whereas IL-8 secretion increased only of 1.4 times in CF cells.
Conclusions: CF respiratory epithelial cells exhibit a basal dysregulated production of IL-8 that partially correlates to enhanced NF-nB
activity. Our data corroborate the hypothesis of a basal exaggerated inflammatory response in the CF respiratory epithelium.
D 2006 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic fibrosis; Inflammation; Interleukin 1-h; Pseudomonas aeruginosa; Respiratory epithelial cells1. Introduction
Chronic pulmonary disease is the most prominent clinical
feature of cystic fibrosis (CF) patients. CF is caused by
mutations in the CF transmembrane conductance regulator
(CFTR) gene resulting in defective regulation of chloride
transport by epithelial cells. The direct consequence of
defective CFTR function is believed to be alteration of the
airway epithelial cells that brings to depletion of airway
surface fluid that results in mucus plugging and airway
obstruction. Infection with microorganisms, particularly1569-1993/$ - see front matter D 2006 European Cystic Fibrosis Society. Publish
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follows. The inflammatory response to chronic infection is
characterized by excessive neutrophil influx in the airways
due to the increased local production of interleukin (IL)-8, a
potent chemoattractant for neutrophils, mainly by airway
epithelial cells [1]. This determines a vicious cycle of
infection and inflammation, which ultimately destroys the
lung [2].
Clinical and experimental evidences support the notion
that in CF there is tendency toward excessive inflammation
following bacterial colonization and infection. Muhlebach et
al. [3] reported that bronchoalveolar lavage fluid (BALF)
from infected children with CF contained significantly more
IL-8 and neutrophils than BALF from infected children with5 (2006) 113 – 119ed by Elsevier B.V. All rights reserved.
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inflammatory response was higher than that in control
subjects but with a comparable airway burden of bacteria
[3]. CF mice die earlier and to a greater extent from chronic
P. aeruginosa infection than their non-CF littermates, and
this increased death rate is accompanied by increased
proinflammatory cytokines in BALF but not by an increased
bacterial burden [4]. Kube et al. [5] have shown that CF cell
lines produce significantly more IL-8 and granulocyte-
macrophage colony-stimulating factor in response to P.
aeruginosa than control lines, and, importantly, the differ-
ences widens over time. Finally, Stecenko et al. [6] found
that there is an accelerated and exaggerated IL-8 and IL-6
generation in CF cells upon stimulation with TNF-a or IL-
1h.
In the last years a new concept has emerged about the
pathogenesis of CF lung disease, and that airway
inflammation is not simply a direct consequence of
bacterial colonization of the respiratory tract but can be
endogenously triggered. The hypothesis of primary in-
flammation came firstly from clinical observations of
inflammation preceding detectable infection in CF neo-
nates and young children [7,8]. Both the number of
neutrophils and IL-8 levels were increased in BALF of
CF patients as compared to control subjects, with negative
cultures for common bacterial CF-related pathogens. In
primary epithelial cells of respiratory origin it was possible
to show that IL-8 is produced at higher levels than in non-
CF counterparts under basal conditions [9–11]. Tabary et
al. [11,12] demonstrated both in vivo and in vitro that CF
bronchial submucosal gland epithelial cells exhibit a
selective up regulation of IL-8 production, associated with
constitutively activated nuclear factor (NF)-nB and the
absence of InB kinase a. Raia et al. [13] have shown that
higher number of epithelial cells with NF-nB p65 nuclear
localization were observed in CF nasal polyps than
controls prior to any challenge.
In this study it was examined whether there is evidence
for basally increased IL-8 production and NF-nB activation
to support the hypothesis of an intrinsic dysregulated
inflammatory response in CF airway epithelial cells. To
assess the other hypothesis of excessive inflammation
following infection, it has been studied whether in CF,
stimulation with P. aeruginosa or pro-inflammatory cyto-
kines results in exaggerated production of IL-8. To avoid
contradictory results previously obtained with immortalized
cell lines [6,14–19], we have used a model of primary
airway epithelial cells obtained from nasal polyps.2. Methods
2.1. Study subjects
Fresh nasal polyps were obtained from 14 non-CF and 14
CF patients undergoing nasal polypectomy due to nasalobstruction and immediately processed. Informed consent
was obtained from all patients or their parents. The protocol
was approved by the Institutional Review Board (Istituti
Clinici di Perfezionamento, Milano). CF patients (9 males,
mean ageTSD, 17.7T7.2) were six DF508 homozygous,
one R1162X homozygous, and seven compound heterozy-
gous (three DF508/unknown, one N1303K/E585X, one
DF508/1717-1GA, one DF508/3849+10 Kb, one 1717-
1GA/G542X). In all patients, the diagnosis of CF was based
on iontophoretic sweat chloride levels of >60 mEq/L in a
pilocarpine-induced sweat sample of >100 mg, and patients
were screened for 31 most common mutations of CFTR
genotypes occurring in the study population [20]. All CF
patients, except two, had severe lung disease and were
pancreatic insufficient. Lung secretions (sputum) from all
these patients contained P. aeruginosa (n =8), S. aureus
(n =7), Hemophilus parainfluenzae (n =1), Burkholderia
cepacia (n =1), and Alcaligenes xylosoxidans (n =1) on
culture. Non-CF subjects had the same age and sex
distribution of CF patients.
2.2. Explant outgrowth culture of nasal epithelial cells
Respiratory epithelial cells were cultured from nasal
polyps, as already described [21,22]. Briefly, explants (1–2
mm2 in size) of human nasal polyps were seeded onto 60-
mm tissue culture dishes coated with type I collagen
associated with carbodiimide (Sigma, St. Louis, MO).
Explants were then incubated in serum-free RPMI-1640
culture medium in the presence of 2 mM l-glutamine, 1 Ag/
ml insulin, 1 Ag/ml transferrin, 10 ng/ml epidermal growth
factor, 0.5 Ag/ml hydrocortisone, 10 ng/ml retinoic acid, 100
U/ml penicillin, and 100 Ag/ml streptomycin. The out-
growths were cultured for 2–4 weeks, and no difference
was observed in cell growth between CF and non-CF
outgrowths [22].
2.3. Immortalized cells
A549 (human lung carcinoma) cells were grown in
DMEM/Ham’s F12 (1 :1) containing 10% fetal calf serum
(FCS) and antibiotics. A549 cell line was purchased from
American type Culture Collection (ATCC, Rockville, MA).
2.4. Stimulation procedure of respiratory epithelial cells
A multiresistant nonmucoid strain of P. aeruginosa,
isolated from a CF patients, and the commercial strain
PAO1 [23] were grown in TSB (Trypticase Soy Broth)
medium to late-log phase (optical density of 0.23–0.27),
washed, and resuspended in culture medium for nasal
epithelial cells. Nasal outgrowths were trypsinized and cells
were plated on 24-well plates at the density of 100,000 cells/
well in 1 ml of culture medium for 48 h. Typically we obtain
the 50% confluency by this procedure. A549 cells were
trypsinized and seeded at the density of 40,000 per well to
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protocols to stimulate cells. In the first protocol, the
bacterial suspension (clinical isolate) was added to nasal
epithelial cells in a volume of 1 ml at a final concentration
of 5104 cfu/ml for 60 min at 37 -C. TNF-a and IFN-g
were added to cells at final concentrations of 10 ng/ml and
100 U/ml, respectively, for 60 and 30 min. At the end of the
incubations, cells were washed in ice-old PBS and
processed for EMSA. The conditioned media were collected
for further analysis on IL-8 (see below). In the second
protocol, the bacterial suspension (PAO1) was added to
nasal epithelial cells in a volume of 1 ml at a final
concentration of 1108 cfu/ml for 60 min at 37 -C.
Cells were washed and further incubated in RPMI-1640
medium containing gentamicin (400 Ag/ml) for 4 h. TNF-a
(10 ng/ml) or IL-1h (30 ng/ml)/ H2O2 (100 AM) was added
to nasal cells for 5 h. Nuclear extracts and conditioned
media were used to evaluate NF-nB activity and IL-8 levels,
respectively. Control cells were incubated with medium
throughout the whole experiment in both protocols and
these were considered basal conditions. In either protocols
of bacterial infection, cell mortality, as assessed using the
trypan blue exclusion test, did not exceed 10%, and there
was no difference between CF and non-CF cells.
2.5. Nuclear extracts
Cells were lysed in extract buffer containing 10 mM
HEPES, pH 7.9, 10 mM KCl, 0.1 mM EGTA, 0.1 mM
EDTA, 1.5 mM MgCl2, 1 mM DTT, 0.5 mM PMSF, 0.2%
Nonidet-P40, scraped, and centrifuged at 12,000 g for 20 s
at 4 -C. The nuclear pellet was resuspended in extract buffer
added with 420 mM NaCl and 20% glycerol and the nuclei
were incubated on ice rocking for 30 min. Nuclear debrisFig. 1. Basal and induced NF-nB activity in primary respiratory nasal and A549
60 min or TNF-a (10 ng/ml) for 30 min prior to the preparation of nuclear extracts
by EMSA. In lanes 2, 4, 6, 8, 10, 12, and 15, a 50-fold excess of unlabeled NF
migrated slightly faster in A549 than in nasal cells. (B) Nasal cells (2 weeks-old) w
5104 cfu/ml) for 1 h. The arrows and the asterisks denote the specific band anwere removed by centrifugation (12,000 g at 4 -C), and
the protein concentration of the nuclear extract was
determined. The nuclear extracts were stored at 80 -C
until further use.
2.6. Electrophoretic mobility-shift assay (EMSA)
EMSA was done as previously described [24]. Equiva-
lent amounts of nuclear protein (5 Ag) were incubated on ice
for 10 min in a buffer containing 12.5 mM HEPES, pH 7.9,
0.5 mM EDTA, 50 mM KCl, 1 mM MgCl2, 10% Ficoll, and
2.5 Ag poly-dIdC (Amersham, Uppsala, Sweden). EMSA
probe for NF-nB was obtained from Genzyme (Cambridge,
MA). nB sequence was taken from the immunodeficiency
v i r u s l ong t e rm i n a l r e p e a t [ 2 5 ] : 5 V- TAGG-
GACTTTCCGCTGGGGACTTTCCAG-3V. The probe was
end-label with 32P, using T4 kinase (Promega, Madison,
WI), after which unincorporated nucleotides were removed
with a G-25 Sephadex separation column (Roche Molecular
Biochemicals, Basel, Switzerland). The labeled probe
(100,000 cpm) was then added to nuclear extracts and
incubated with the reaction mixture for additional 10 min at
room temperature. Bound and free probe were resolved
through nondenaturing 6% polyacrylamide gel electropho-
resis (PAGE). Specificity of the binding was evaluated by
adding 20-fold excess of unlabelled double-stranded oligo-
nucleotide to the binding reaction 10 min before the addition
of the labeled probe. To identify the factors that bound to the
NF-nB site, nuclear extracts were incubated with 1 Al of a
rabbit antiserum either to p65 or to p50. A non-immune
rabbit serum was used as a control. Sera were purchased
from Santa Crux Biotechnology, Inc. (Santa Cruz, CA). X-
ray films (Bio Max, Kodak, New York, NY) were exposed
over night.cells. (A) Cells were either untreated or treated with IFN-g (100 U/ml) for
. 2.5 Ag of each nuclear extract were analyzed for nB-DNA binding activity
-nB oligonucleotide was added to the reaction mixture. NF-nB complexes
ere either untreated or incubated with a clinical isolate of P. aeruginosa (PA;
d the free probe, respectively.
Fig. 2. Time course of IL-8 secretion by non-CF and CF nasal outgrowths.
Nasal polyps (non-CF=4; CF=5) were plated as 1–2 mm2 explants onto
60-mm plate dishes and conditioned medium was collected after 2, 5, 7, 10,
and 15 days. *P=0.0001 CF vs. non-CF at each time point.
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In some experiments, the activity of NF-nB p65 was
measured by using a commercial kit (TransAMi NF-nB,
Active Motif Europe, Rixensart, Belgium). Briefly, nuclear
extracts were added to wells coated with an oligonucleotide
containing a NF-nB consensus binding site. The binding
was revealed by consequent addition of a primary antibody
directed against p65 and a secondary antibody conjugated to
horseradish peroxidase and, after the addition of the
substrate, absorbance was read at 450 nm. The amount of
active NF-nB p65 of each sample was obtained against a
standard curve and normalised on the protein content.
2.8. Immunoreactive IL-8 assay
IL-8 secretion over time was evaluated in 1–2 mm2 nasal
polyp explants cultured onto 60-mm plate dishes up to two
weeks. In the other experiments, the outgrowths were
trypsinized and cells plated onto wells of 24-well plates
(see above). In both cases, cell culture supernatants were
collected and spun at 12,000 g for 15 min at 4 -C. The
supernatants were stored at 80 -C until further use.
Immunoreactive IL-8 levels were quantified using commer-
cially available sandwich ELISA kit from Amersham.
2.9. Statistical analysis
Data are reported as meanTSEM. Statistical significance
of differences was evaluated by a two-tailed unpaired
Student’s t-test. A value of P <0.05 was considered
significant.Fig. 3. Evaluation of NF-nB p65 nuclear activity by a colorimetric assay in
CF and non-CF nasal epithelial cells under basal conditions and following
exposure to P. aeruginosa PAO1 (PA; 1108 cfu/ml) for 5 h (see Methods)
or costimulation with IL-1h (30 ng/ml)/H2O2 (100 AM) for 5 h. *P=0.0001
PA vs. basal and IL-1h/H2O2 vs. basal;
‘P=0.0004 basal CF vs. basal non-
CF; #P=0.0001 PA vs. basal and IL-1h/H2O2 vs. basal.3. Results
3.1. NF-jB activity in primary respiratory epithelial cells
We have previously shown that primary nasal epithelial
cells exhibit a de-differentiated phenotype at 2 weeks ofculture, while they undergo squamous differentiation at 4
weeks [22]. In nuclear extracts obtained from non-CF nasal
respiratory cells a band shift with an oligonucleotide
containing the NF-nB consensus sequence was found
(Fig. 1). Specificity of the complex was demonstrated by
competition with the unlabelled oligonucleotide. An anti-
body to p65 caused a supershift of the complex, whereas an
anti-p50 antibody did not affect the formation and the
mobility of the complex (not shown). Under basal con-
ditions, four weeks-old squamous cells exhibited a higher
NF-nB activity than two weeks-old de-differentiated cells.
NF-nB activity increased when de-differentiated nasal
respiratory cells were incubated with pro-inflammatory
cytokines, such as TNF-a or IFN-g, or upon exposure to
P. aeruginosa (5104 cfu/ml) for 1 h. On the other hand,
squamous cells were responsive to TNF-a but not to IFN-g,
similarly to A549 cells which we have already shown to be
insensitive to IFN-g [21].
3.2. Time course of IL-8 secretion by primary nasal
epithelial cells
Based on the EMSA results, the study was continued
only on two weeks-old outgrowths. To evaluate IL-8 levels
at the beginning of the culture and whether culture
conditions could modify its secretion, nasal polyp out-
growths were studied at different time points after plating. In
non-CF outgrowths, basal IL-8 was found to be secreted at
low levels and did not change over the 2 weeks of culture
(Fig. 2). CF outgrowths gave significantly higher levels than
non-CF outgrowths at all the time points considered.
3.3. NF-jB activity in CF and non-CF cells
We sought then to evaluate whether there was a
difference in basal and stimulated NF-nB nuclear activity
between primary respiratory epithelial cells of CF and non-
CF origin. Preliminary experiments were carried out with
the clinical strain of P. aeruginosa (500 bacteria/cells for
1 h). Densitometric analysis of EMSAs showed that CF
Fig. 4. IL-8 levels in supernatants of CF and non-CF nasal cells under basal
condition and following exposure to P. aeruginosa PAO1 (PA; 1108 cfu/
ml) for 5 h (seeMethods) or co-stimulation with IL-1h (30 ng/ml)/H2O2 (100
AM). *P=0.0001 PA vs. basal and IL-1h/H2O2 vs. basal; ‘P=0.0025 basal
CF vs. basal non-CF; #P=0.44 PAvs. basal; **P=0.61 IL-1h/H2O2 vs. basal.
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cells, and that P. aeruginosa caused almost two- and four-
fold increase in NF-nB activity in CF and non-CF cells,
respectively (not shown). To better assess differences
between CF and non-CF cells, we used the commercial
strain PAO1 [23], increased the bacterial load of cells to
1108 cfu/ml (1000 bacteria/cell) and prolonged the
exposure time to 5 h [26]. To study NF-nB activation in a
consistent and quantitative way, a colorimetric assay was
used [27]. Nasal cells were co-stimulated with IL-1h and
H2O2, previously shown to induce maximal activation of
NF-nB activity in human tracheobronchial epithelial cells
[28]. Under basal conditions, CF cells presented a signif-
icant higher activity of NF-nB than non-CF cells (Fig. 3).
Challenge with P. aeruginosa or co-stimulation with IL-1h/
H2O2 increased NF-nB activity by four and two times in
non-CF and CF cells, respectively.
3.4. IL-8 secretion by CF and non-CF cells
IL-8 secretion was preliminarily studied in the condi-
tioned media of the same cells processed for NF-nB EMSA
assay (i.e. using the first protocol of stimulation with the
clinical strain of P. aeruginosa). IL-8 levels were signifi-
cantly higher in CF than in non-CF cells. Incubation of cells
with P. aeruginosa resulted in a greater increase in IL-
8 secretion by non-CF than by CF cells (not shown). To
confirm these results, in parallel to the study of NF-nB
activation by means of PAO1 strain with the second
protocol, conditioned media were evaluated for IL-8 secre-
tion. Comparing unstimulated non-CF and CF cells, IL-
8 levels were significantly higher in CF than in non-CF cells
(Fig. 4). Incubation of cells with P. aeruginosa resulted in a
greater increase in IL-8 secretion by non-CF than by CF
cells (6.3 and 1.4 fold, respectively). Costimulation with IL-
1h/H2O2 determined an increase in IL-8 secretion compa-
rable to that obtained with P. aeruginosa challenge in either
CF and non-CF cells (Fig. 4). These data show that either
infection and inflammatory stimuli induce less IL-8 produc-
tion in CF cells than in non-CF cells.4. Discussion
In this study we show that in primary respiratory
epithelial cells obtained ex vivo from nasal polyps, IL-8 is
constitutively elevated in CF patients as compared to non-
CF subjects. Nasal polyps may not reflect the inflammatory
response at the level of the lower airway inflammatory. Few
studies have directly compared inflammatory parameters in
upper and lower airways. Noah et al. [29] found that neither
inflammatory cells nor cytokine concentrations in nasal
lavage fluid differed between CF patients and controls,
whereas IL-8 levels in BALF from children with CF were
markedly elevated compared with levels in controls. Most
recently, Pitrez et al. [30] showed in young children with CF
that IL-8 concentrations and neutrophil percentages in the
nasal wash correlated significantly with those in BALF.
Further study are needed to understand whether nasal lavage
fluid may be a surrogate indicator for lower airway
inflammation. However, the nasal polyp model used in
our study likely reflects the pre-existing local inflammation
in CF, as shown from the higher basal levels of IL-8 at the
beginning of the culture (Fig. 2). Moreover, the low levels
of NF-nB activity in nuclear extracts (Fig. 1) and of IL-8 in
conditioned media (Figs. 2 and 4) found in non-CF cells
under basal conditions, show that nasal epithelial cells
obtained from non-CF patients were in a low pro-
inflammatory status.
CF cells obtained from two weeks-old outgrowths
exhibited higher basal levels of IL-8 than non-CF nasal
cells (Fig. 4), confirming similar results obtained in other
primary airway epithelial cell types [9–11]. Tabary et al.
studied primary bronchial submucosal gland cells obtained
from lung transplant operations [11,12] and so did
Kammouni et al., who analyzed tracheal gland serous
cells [9]. Bonfield et al. demonstrated high IL-8 basal
levels in fresh bronchial epithelial cells obtained by
bronchial brushing [10]. We used primary cultures of
airway epithelial cells that outgrow from nasal polyps,
thereby using a less invasive technique than bronchial
brushings; moreover, nasal polyps are more easily acces-
sible than lung transplants. Considering also that immor-
talized cell lines have given contradictory results as
concerning IL-8 production in CF cells [6,14–18], our
model has the advantage to be based on primary cultures
of airway epithelial cells obtained from specimens which
are relatively simple to obtain.
The consequences of the presence of a mutated form of
the CFTR protein on IL-8 synthesis and secretion have been
poorly studied [18]. The limit of the model used in this
study is due to the differentiation status of nasal cells which,
under these culture conditions, show a dedifferentiated
phenotype [22]. As judged by immunocytochemistry, the
primary nasal cells used in this study accumulate the CFTR
protein in the cytosol, with no differences between CF and
non-CF cells (not shown). These data may suggest that other
genes, dysregulated or mutated in CF, may determine an
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influence the severity of the lung disease [31].
Incubation of CF cells with P. aeruginosa increased only
1.4 times the secretion of IL-8. This result could be due to
the formation of tight junctions between the cells. Indeed, it
has been shown the lack of apoptotic response to P.
aeruginosa in tight junction-forming airway epithelial cells
[32]. However, two lines of evidence do not support this
notion under our experimental conditions. First, non-CF
cells responded to P. aeruginosa by increasing IL-8 secretion
by 6.3 times. Second, when primary nasal epithelial cells are
grown on a thin film of collagen, like in our study, they do
not form tight junctional complexes [33]. Thus it is likely
that CF nasal epithelial cells cannot produce any more IL-
8 above that secreted, indicating that CF cells are exhausted
in what concerns IL-8 synthesis. This is confirmed by co-
stimulation of nasal epithelial cells with IL-1h/H2O2,
previously shown to induce maximal activation in tracheo-
bronchial epithelial cells. Alternatively, the early time point
at which we have studied the IL-8 response (5 h) may have
not allowed to detect a further increased secretion. Indeed,
differences in IL-8 gene expression between CF and non-CF
cells became more apparent at time points later than 4 h after
stimulation with whole P. aeruginosa bacteria [34] or with
P. aeruginosa filtrates [35]. Joseph et al. [34] have shown
that upon stimulation of CF airway epithelial cells with P.
aeruginosa, the inhibitor InBa can translocate into the
nucleus blocking NF-nB at earlier times. Accordingly, we
found increased NF-nB translocation into the nucleus (Fig.
3) but no robust IL-8 secretion in CF cells upon P.
aeruginosa challenge or co-stimulation with IL-1h/H2O2.
These results are in agreement with those presented by other
authors in primary epithelial respiratory cells. Becker et al.
[35] showed that IL-8 production by well and poorly
differentiated CF human tracheobronchial cells is not
significantly increased above basal levels upon IL-1h and
TNF-a stimulation. Aldallal et al. [17] demonstrated that
human CF tracheobronchial epithelial cells in primary
culture released moderately increased IL-8 only after
exposure to P. aeruginosa and not to proinflammatory
cytokines. Kammouni et al. [9] showed that human CF
tracheal gland serous cells secreted increased levels of IL-
8 upon treatment with P. aeruginosa LPS. To our best
knowledge, the only report on primary nasal cells was
published by Scheid et al. [14]. They found that incubation
with P. aeruginosa resulted in a significant increase in IL-
8 secretion from CF cells. Although different from our data,
these results might be due to the use of epithelial cells
obtained from nasal brushings and to the experimental
procedure of stimulation. In summary, the source of primary
respiratory epithelial cells might condition the outcome of
the stimulation procedure.
NF-nB is a transcription factor central to the inflamma-
tory response and cytokine production [36]. IL-8 generation
is mainly dependent from NF-nB [37] and few studies have
pointed out that NF-nB nuclear translocation from cytosol isconstitutively upregulated in primary CF airway epithelial
cells [12,34]. Here we show that CF nasal epithelial cells
behave in the same manner, i.e. display an exaggerated basal
NF-nB activity as compared to non-CF cells. Interestingly, it
has been recently shown that CF nasal polyps display higher
NF-nB p65 nuclear localization than control polyps soon
after their surgical removal [13]. The less increase of NF-nB
basal activity with respect to IL-8 secretion in CF cells as
compared to non-CF cells indicates that the dysregulation of
other transcription factor(s) may be involved in IL-8 high
basal secretion by CF cells. NF-IL6, a member of C/EBP
superfamily of transcription factor, which is involved in
inducible gene expression during acute infections and
inflammatory processes [38,39], is a strong candidate.
Indeed, NF-nB and NF-IL6 act synergistically to promote
transcription of both IL-6 and IL-8 [39].
In summary, our data show that IL-8 basal production is
elevated in CF cells and this partially correlates to enhanced
NF-nB activity. CF cells are not responsive to bacterial or
cytokine challenge, likely because they have an impairment
in intra-nuclear NF-nB activity or are exhausted in IL-
8 synthesis. Our data corroborate the hypothesis of a basal
dysregulated inflammatory response in the CF respiratory
epithelium.Acknowledgements
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